期刊
CLINICAL CANCER RESEARCH
卷 22, 期 4, 页码 787-789出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-15-2777
关键词
-
类别
资金
- Leukemia & Lymphoma Society
- Damon Runyon Cancer Research Foundation
- American Society of Hematology
Kenkre and colleagues report the absence of correlation between Fc gamma RIIIa-V158F polymorphism and rituximab response in follicular lymphoma patients, a result which is in contrast with prior studies. This discrepancy recalls that many other factors (from the host and from the tumor) may influence the efficacy of rituximab in vivo. (C) 2015 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据